Erectile Dysfunction Market Rising

Viagra, Cialis and Levitra are the drugs that dominate the market...

According to a business research group called Datamonitor the erectile dysfunction drug market increased by three and a half percent from the year 2004 to 2005 making it worth almost one billion pounds sterling. Datamonitor attributed the rise in erectile dysfunction drug sales to a sexually active aging population, the increase in obesity as well as a bigger acceptance of the normality of using these drugs to enhance sexual performance. It is still estimated that thousands and thousands of men despite suffering from erectile dysfunction do not have the courage to come forward and use erectile dysfunction medication and thus there is still a large untapped market for these impotence medications.

Viagra, Cialis and Levitra are the drugs that dominate the market for erectile dysfunction but are likely to face competition from fresh entrants into the market in the near future.  Datamonitor say that there are at least 21 research projects presently working on new erectile dysfunction medications. Just recently at Ukmedix News we reported on a new erectile dysfunction drug that will be administered in the way of an inhaler and thus will work extremely quickly in as little as one minute. Most erectile dysfunction drugs take up to half an hour to start working.

One of the biggest problems that the erectile dysfunction drug Levitra has is that it does not appear to differ at all from the erectile dysfunction drug Viagra. The sales of the drug Cialis have been far better because it has a unique selling point in that it works for 36 hours as opposed to four hours for the other two drugs. The new drugs that come on the market to help men with erectile dysfunction must display unique selling points in order to differentiate them from the competition. The inhaler is likely to sell well if it gets full approval from the medical authorities in the European Union and in America.